Innovent's SYCUME Delivers Phase 3 Win In Inactive Thyroid Eye Disease
(RTTNews) - Innovent's SYCUME Delivers Phase 3 Win in Inactive Thyroid Eye Disease
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.